Medlive Technology Co., Ltd.

SEHK:2192 Rapport sur les actions

Capitalisation boursière : HK$5.9b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Medlive Technology Bilan de santé

Santé financière contrôle des critères 6/6

Medlive Technology possède un total de capitaux propres de CN¥4.6B et une dette totale de CN¥0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont CN¥4.9B et de CN¥248.6M. L'EBIT de Medlive Technology est CN¥65.1M ce qui fait que son ratio de couverture des intérêts -0.4. Elle dispose de liquidités et de placements à court terme de CN¥4.4B.

Informations clés

0%

Ratio d'endettement

CN¥0

Dette

Ratio de couverture des intérêts-0.5x
Argent liquideCN¥3.86b
Fonds propresCN¥4.73b
Total du passifCN¥214.01m
Total des actifsCN¥4.94b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 04
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Apr 08
Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Feb 20
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Jan 10
Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 27
Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Jul 10
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

May 11
Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

May 02
Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 26
Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

Feb 06
Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Oct 31
There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 14
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Apr 03
These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Feb 22
Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 2192 ( CN¥4.6B ) dépassent ses passifs à court terme ( CN¥189.8M ).

Passif à long terme: Les actifs à court terme de 2192 ( CN¥4.6B ) dépassent ses passifs à long terme ( CN¥58.8M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: 2192 est sans dette.

Réduire la dette: 2192 n'avait aucune dette il y a 5 ans.

Couverture de la dette: 2192 n'a pas de dette, elle n'a donc pas besoin d'être couverte par le flux de trésorerie opérationnel.

Couverture des intérêts: 2192 n'a aucune dette, par conséquent la couverture des paiements d'intérêts n'est pas un problème.


Bilan


Découvrir des entreprises saines